Patents by Inventor Jacqueline M. Achkar

Jacqueline M. Achkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • High-Affinity Mycobacterium Tuberculosis Capsule-Specific Human Monoclonal Antibody
    Publication number: 20240101650
    Abstract: Provided are high affinity Mycobacterium tuberculosis arabinomannan-specific antibodies and antigen-binding fragments thereof. Also provided are methods of use and devices employing such Mycobacterium tuberculosis arabinomannan-specific antibodies and antigen-binding fragments thereof.
    Type: Application
    Filed: December 15, 2021
    Publication date: March 28, 2024
    Inventors: Jacqueline M. Achkar, Elise Ishida, Yanyan Liu, Tingting Chen
  • High-Affinity Mycobacterium Tuberculosis Capsule-Specific Human Monoclonal Antibody
    Publication number: 20230365663
    Abstract: Provided are high affinity Mycobacterium tuberculosis capsule-specific antibodies and fragments thereof, as well as methods of use and devices employing such antibodies and/or fragments.
    Type: Application
    Filed: April 28, 2023
    Publication date: November 16, 2023
    Applicant: Albert Einstein College of Medicine
    Inventors: Jacqueline M. Achkar, Jonathan Lai, Elise Ishida, Daniel Hofmann, Tingting Chen
  • High-affinity capsule-specific human monoclonal antibody
    Patent number: 11643455
    Abstract: Provided are high affinity Mycobacterium tuberculosis capsule-specific antibodies and fragments thereof, as well as methods of use and devices employing such antibodies and/or fragments.
    Type: Grant
    Filed: December 15, 2020
    Date of Patent: May 9, 2023
    Assignee: Albert Einstein College of Medicine
    Inventors: Jacqueline M. Achkar, Jonathan Lai, Elise Ishida, Daniel Hofmann, Tingting Chen
  • METHODS FOR ASSESSING THE RISK OF DEVELOPING ACTIVE TUBERCULOSIS
    Publication number: 20220326236
    Abstract: This disclosure describes markers that are associated with active tuberculosis (TB) and demonstrates that the disclosed markers can be used as a biomarker for determining whether a subject has or is at risk of having active TB and for the early detection of HIV-associated TB. This disclosure also provides methods of screening subjects who are thought to be at risk for developing active TB, methods of determining the efficacy of therapeutic regimens for preventing or treating active TB, and methods of identifying anti-TB agents.
    Type: Application
    Filed: October 2, 2020
    Publication date: October 13, 2022
    Applicant: Albert Einstein College of Medicine
    Inventors: Jacqueline M. Achkar, Eustache Paramithiotis
  • HIGH-AFFINITY MYCOBACTERIUM TUBERCULOSIS CAPSULE-SPECIFIC HUMAN MONOCLONAL ANTIBODY
    Publication number: 20210163578
    Abstract: Provided are high affinity Mycobacterium tuberculosis capsule-specific antibodies and fragments thereof, as well as methods of use and devices employing such antibodies and/or fragments.
    Type: Application
    Filed: April 12, 2019
    Publication date: June 3, 2021
    Inventors: Jacqueline M. Achkar, Jonathan Lai, Elise Ishida, Daniel Hofmann, Tingting Chen
  • HIGH-AFFINITY MYCOBACTERIUM TUBERCULOSIS CAPSULE-SPECIFIC HUMAN MONOCLONAL ANTIBODY
    Publication number: 20210130443
    Abstract: Provided are high affinity Mycobacterium tuberculosis capsule-specific antibodies and fragments thereof, as well as methods of use and devices employing such antibodies and/or fragments.
    Type: Application
    Filed: December 15, 2020
    Publication date: May 6, 2021
    Inventors: Jacqueline M. Achkar, Jonathan Lai, Elise Ishida, Daniel Hofmann, Tingting Chen